Multi-slice CT contrast-enhanced presentations of advanced gastric cancer: Associations with histo-differentiation and expression of p53 and P-glycoprotein

Chinese Medical Journal

Volumn 121, Issue 24, 2008, Pages 2487-2491

  Yin, Xin Dao ^a   Zhao, Jian Hua ^a   Zhang, Lin ^a   Wang, Li Ping ^a   Lu, Ling Qu ^a   Wang, Li Wei ^a   Xie, Guang Hui ^a   Wu, Qian Zhi ^a   Wang, Shu Zhi ^a   Gu, Jian Ping ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Gastric cancer; Multi slice CT; P gp; p53

Indexed keywords

GLYCOPROTEIN P; IOPROMIDE; PROTEIN P53;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER INVASION; CANCER SIZE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; OUTCOME ASSESSMENT; PROTEIN DETERMINATION; PROTEIN EXPRESSION; STOMACH CANCER; STOMACH SURGERY; STOMACH WALL;

EID: 60649084999     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200812020-00004     Document Type: Article

References (23)

1. Devesa SS, Blot WJ, Fraumeni JF. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998; 83: 2049-2053.
2. Gabbert HE, Müller W, Schneiders A, Meier S, Hommel G The relationship of p53 expression to the prognosis of 418 patients with gastric carcinoma. Cancer 1995; 76: 720-726.
3. Seo YH, Joo YE, Choi SK, Rew JS, Park CS, Kim SJ. Prognostic significance of p21 and p53 expression in gastric cancer. Korean J Intern Med 2003; 18: 98-103.
4. Maehara Y, Tomoda M, Hasuda S, Kabashima A, Tukunaga E, Kakeji Y, et al. Prognostic value of p53 protein expression for patients with gastric cancer: a multivariate analysis. Br J Cancer 1999; 79: 1255-1261.
5. Zafirellis K, Karameris A, Milingos N, Androulakis G. Molecular markers in gastric cancer: can p53 and bcl-2 protein expressions be used as prognostic factors? Anticancer Res 2005: 25: 3629-3636.
6. Monden N, Abe S, Sutoh I, Hishikawa W, Kinugasa S, Nagasue N. Prognostic significance of the expressions of metallothionein, glutathione-S-transferase-pi, and P-glycoprotein in curatively resected gastric cancer. Oncology 1997; 54; 391-399.
7. Fujii H, Tanigawa N, Muraoka R, Shimomatsuya T, Tanaka T. Clinical significance of multidrug resistance and P-glycoprotein expression in patients with gastric carcinoma. J Surg Oncol 1995; 58: 63-69.
8. Xie HL, Su Q, He XS, Liang XQ, Zhou JG, Song Y, et al. Expression of p21WAF1 and p53 and polymorphism of p21WAF1 gene in gastric carcinoma. World J Gastroenterol 2004; 10: 1125-1131.
9. Gurel S, Yerci O, Filiz G, Dolar E, Yilmazlar T, Nak SG, et al. High expression of multidrug resistance-1 (MDR-1) and its relationship with multiple prognostic factors in gastric carcinomas in patients in Turkey. J Int Med Res 1999; 27: 79-84.
10. Park MS, Yu JS, Kim MJ, Yoon SW, Kim SH, Noh TW, et al. Mucinous versus nonmucinous gastric carcinoma: differentiation with helical CT. Radiology 2002; 223: 540-546.
11. Kadowaki K, Murakami T, Yoshioka H, Kim T, Takahashi S, Tomoda K, et al. Helical CT imaging of gastric cancer: normal wall appearance and the potential for staging. Radiat Med 2000; 18: 47-54.
12. Habermann CR, Weiss F, Riecken R, Honarpisheh H, Bohnacker S, Staedtler C, et al. Preoperative staging of gastric adenocarcinoma: comparison of helical CT and endoscopic US. Radiology 2004; 230: 465-471.
13. Rossi M, Broglia L, Graziano P, Maccioni F, Bezzi M, Masciangelo R, et al. Local invasion of gastric cancer: CT findings and pathologic correlation using 5-mm incremental scanning, hypotonia, and water filling. Am J Roentgenol 1999; 172: 383-388.
14. Kumano S, Murakami T, Kim T, Hori M, Iannaccone R, Nakata S, et al. T staging of gastric cancer: role of multi - detector row CT. Radiology 2005; 237: 961-966.
15. Kim JH, Eun HW, Choi JH, Hong SS, Kang W, Auh YH. Diagnostic performance of virtual gastroscopy using MDCT in early gastric cancer compared with 2D axial CT: focusing on interobserver variation. Am J Roentgenol 2007; 189: 299-305.
16. Wei WZ, Yu JP, Li J, Liu CS, Zheng XH. Evaluation of contrast-enhanced helical hydro-CT in staging gastric cancer. World J Gastroentero1 2005; 11: 4592-4595.
17. Kang BC, Kim JH, Kim KW, Lee DY, Baek SY, Lee SW, et al. Value of the dynamic and delayed MR sequence with Gd-DTPA in the T-staging of stomach cancer: correlation with the histopathology. Abdom Imaging 2000; 25: 14-24.
18. Ishii HH, Gobé GC, Pan W, Yoneyama J, Ebihara Y. Apoptosis and cell proliferation in the development of gastric carcinomas: associations with c-myc and p53 protein expression. J Gastroenterol Hepatol 2002; 17: 966-972.
19. Lee DY, Park CS, Kim HS, Kim JY, Kim YC, Lee S. Maspin and p53 protein expression in gastric adenocarcinoma and its clinical applications. Appl Immunohistochem Mol Morphol 2008; 16: 13-18.
20. Pan W, Ishii H, Ebihara Y, Gobe G. Prognostic use of growth characteristics of early gastric cancer and expression patterns of apoptotic, cell proliferation and cell adhesion proteins. J Surg Oncol 2003; 82: 104-110.
21. Lacueva FJ, Calpena R, Medrano J, Teruel A, Mayol MJ, Graells ML. Changes in P-glycoprotein expression in gastric carcinoma with respect to distant gastric mucosa may be influenced by p53. Cancer 2000; 89: 21-28.
22. Oliver I, Lacueva J, Barberá V, Caldes T, Teruel A, Costa D, et al. p53 genetic abnormalities and P-glycoprotein expression in stump and primary gastric carcinomas. Hepatogastroenterology 2007; 54: 377-381.
23. Tan YJ, Xie XY, Chen Y. Study on relationship between mutant p53 and multidrug resistance gene 1 in gastric cancer. J Pract Oncol (Chin) 2006; 21: 309-311.